This is a routine resale registration for existing shareholders from a prior private placement, not a new equity raise. The selling pressure is limited to 2.5% of shares outstanding, and the company's strong Q1 results and $50.3M cash position suggest no near-term capital need. Monitor for any subsequent prospectus supplement that could indicate a new primary offering.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 13 $7.10entry
- T+1 · 6mo ago 0.00%α +0.00% · $7.10
- T+5 · 6mo ago −5.21%α −4.05% · $6.73
- T+20 · 5mo ago −6.34%α −5.73% · $6.65
- T+60 · 3mo ago +4.37%α −0.07% · $7.41
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Profound Medical filed an S-3 registration statement to register 921,428 common shares for resale by selling shareholders who acquired them in a December 2025 private placement at $7.00/share. The company is not selling any shares or receiving proceeds from this filing. This is a routine resale registration for existing shareholders, not a new capital raise, and follows strong Q1 2026 results with 104% revenue growth and improved operating performance.
Key Financial Metrics
Key Facts
- S-3 registers 921,428 common shares for resale by selling shareholders from a December 2025 private placement
- Shares were issued at $7.00 per share for aggregate gross proceeds of approximately $6.45 million
- Company will not receive any proceeds from the resale of shares under this prospectus
- Filing follows Q1 2026 earnings (May 7) showing 104% revenue growth to $5.3M and net loss improvement of 34% to $0.19/share
- Company had $50.3M cash as of March 31, 2026, with $59.4M in shareholders' equity
- Selling shareholders include Fidelity True North Fund (300,000 shares) and funds associated with Timelo Investment Management (571,428 shares)
- Registration covers approximately 2.5% of outstanding shares (36.3M shares outstanding as of May 7, 2026)
Financial Impact
No new capital raised; potential overhang of 921,428 shares (2.5% of outstanding) at ~$7.25/share market price, representing ~$6.7M in potential selling pressure
Risk Factors
- Potential overhang from selling shareholders could create near-term downward pressure on stock price
- Fidelity True North Fund and Timelo funds are significant holders; their selling could signal reduced conviction
- Company remains pre-profitable with accumulated deficit of $294.8M and may need additional capital in the future
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001104659-26-059487 |
| Document: tm2614107d1_ex-filingfees.htm | 0001104659-26-059487 |
| Document: tm2614107d1_ex5-1.htm | 0001104659-26-059487 |
| Document: tm2614107d1_ex23-1.htm | 0001104659-26-059487 |
| Document: 0001104659-26-059487-index-headers.html | 0001104659-26-059487 |
| Document: 0001104659-26-059487-index.html | 0001104659-26-059487 |
| Document: 0001104659-26-059487.txt | 0001104659-26-059487 |
Track record
22 reports on PROF
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.21 Now $7.34 −1.80% settles Dec 7
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $7.16 Now $7.34 +2.51% settles Dec 3
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
- Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
- Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
- Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers